<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03450000_1</Organism_ID>
  <Organism>Helicobacter pylori</Organism>
  <Organism_Latin>Helicobacter pylori</Organism_Latin>
  <UniProt_ID>Q9ZLT0</UniProt_ID>
  <Seq_Length>255</Seq_Length>
  <Molecule_Weight>28503</Molecule_Weight>
  <KEGG_ID>hpj:jhp0496</KEGG_ID>
  <Orthology_ID>K01776</Orthology_ID>
  <Function_Summary>Provides the (R)-glutamate required for cell wall biosynthesis (By similarity).</Function_Summary>
  <Catalytic_Mechanism>L-glutamate = D-glutamate.</Catalytic_Mechanism>
  <Pfam_ID>PF01177:Asp_Glu_race</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>32</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>MurI</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: L-glutamate = D-glutamate.</Detail>
      <Keyword>Glutamate racemase activity</Keyword>
      <Ontology_ID>GO:0008881</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5.</Detail>
      <Keyword>Isomerase activity</Keyword>
      <Ontology_ID>GO:0016853</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the cell wall, the rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis.</Detail>
      <Keyword>Cellular cell wall organization</Keyword>
      <Ontology_ID>GO:0007047</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of peptidoglycans, any of a class of glycoconjugates found in bacterial cell walls.</Detail>
      <Keyword>Peptidoglycan biosynthetic process</Keyword>
      <Ontology_ID>GO:0009252</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the surface configuration of a cell.</Detail>
      <Keyword>Regulation of cell shape</Keyword>
      <Ontology_ID>GO:0008360</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MKIGVFDSGVGGFSVLKSLLKARLFDEIIYYGDSARVPYGTKDPTTIKQFGLEALDFFKPHEIELLIVACNTASALALEEMQKYSKIPIVGVIEPSILAIKRQVEDKNAPILVLGTKATIQSNAYDNALKQQGYLNISHLATSLFVPLIEESILEGELLETCMHYYFTPLEILPEVIILGCTHFPLIAQKIEGYFMGHFALPTPPLLIHSGDAIVEYLQQKYALKNNACTFPKVEFHASGDVIWLERQAKEWLKL</Protein_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Unknown</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Unknown</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>murI</Gene_Name>
    <Gene_Alias>glr</Gene_Alias>
    <Genbank_ACCN>NC_000921</Genbank_ACCN>
    <Protein_ACCN>NP_223214</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/889183</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HELICOBACTER PYLORI GLUTAMATE RACEMASE IN COMPLEX WITH D-GLUTAMATE AND AN INHIBITOR</PDB_Title>
      <PDB_ID>2W4I</PDB_ID>
      <Resolution>1.87</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2W4I</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03450005</ASD_Ligand>
      <Ligand_Name>D-GLUTAMIC ACID $1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN- 2-YL]AZETIDIN-3-OL</Ligand_Name>
      <PubMed_Title>Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.</PubMed_Title>
      <Author>Geng B, et al.</Author>
      <Journal>Bioorg Med Chem Lett. 2009 Feb 1;19(3):930-6.</Journal>
      <PubMed_ID>19097892</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Design of Inhibitors of Helicobacter pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty</PDB_Title>
      <PDB_ID>4B1F</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4B1F</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03450008</ASD_Ligand>
      <PubMed_Title>Design of Inhibitors of Helicobacter Pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles Onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty.</PubMed_Title>
      <Author>Basarab, G.S., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:5600</Journal>
      <PubMed_ID>22877632</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HELICOBACTER PYLORI GLUTAMATE RACEMASE IN COMPLEX WITH D-GLUTAMATE</PDB_Title>
      <PDB_ID>2JFY</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2JFY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>D-GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Exploitation of structural and regulatory diversity in glutamate racemases.</PubMed_Title>
      <Author>Lundqvist T, et al.</Author>
      <Journal>Nature. 2007 Jun 14;447(7146):817-22.</Journal>
      <PubMed_ID>17568739</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HELICOBACTER PYLORI GLUTAMATE RACEMASE IN COMPLEX WITH D-GLUTAMATE AND AN INHIBITOR</PDB_Title>
      <PDB_ID>2JFZ</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2JFZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03450001</ASD_Ligand>
      <Ligand_Name>5-METHYL-7-(2-METHYLPROPYL)-2-(NAPHTHALEN- 1-YLMETHYL)-3-PYRIDIN-4-YL-2H
-PYRAZOLO[3,4- D]PYRIMIDINE-4,6(5H,7H)-DIONE$D-GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Exploitation of structural and regulatory diversity in glutamate racemases.</PubMed_Title>
      <Author>Lundqvist T, et al.</Author>
      <Journal>Nature. 2007 Jun 14;447(7146):817-22.</Journal>
      <PubMed_ID>17568739</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HELICOBACTER PYLORI GLUTAMATE RACEMASE IN COMPLEX WITH D-GLUTAMATE</PDB_Title>
      <PDB_ID>2JFX</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2JFX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>D-GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Exploitation of structural and regulatory diversity in glutamate racemases.</PubMed_Title>
      <Author>Lundqvist T, et al.</Author>
      <Journal>Nature. 2007 Jun 14;447(7146):817-22.</Journal>
      <PubMed_ID>17568739</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00471</Pathway_ID>
      <Pathway_Title>D-Glutamine and D-glutamate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of other amino acids</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,252,Trp;site,247,Arg;site,244,Trp;site,150,Glu</Site_Detail>
      <Site_Reference>Lundqvist T, et al. Nature. 2007,447(7146):817-822.;Selwood T, et al. Arch Biochem Biophys. 2012,519(2):131-143.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PubMed_ID>17568739;22182754</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>5.1.1.3</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC5/1/1/3.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03450001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03450008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03451025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>